Economic impact of medication error: a systematic review

2017 ◽  
Vol 26 (5) ◽  
pp. 481-497 ◽  
Author(s):  
Elaine K. Walsh ◽  
Christina Raae Hansen ◽  
Laura J. Sahm ◽  
Patricia M. Kearney ◽  
Edel Doherty ◽  
...  
2021 ◽  
pp. 105991
Author(s):  
Michael Gregorio Ortega-Sierra ◽  
María del Carmen Castillo-Montalvo ◽  
Jesús Alberto Manotas-Berdugo ◽  
Jonhatan Guillermo Jiménez-Chimá ◽  
Maria Paz Bolaño-Romero

Author(s):  
Peter J Gates ◽  
Rae-Anne Hardie ◽  
Magdalena Z Raban ◽  
Ling Li ◽  
Johanna I Westbrook

Abstract Objective To conduct a systematic review and meta-analysis to assess: 1) changes in medication error rates and associated patient harm following electronic medication system (EMS) implementation; and 2) evidence of system-related medication errors facilitated by the use of an EMS. Materials and Methods We searched Medline, Scopus, Embase, and CINAHL for studies published between January 2005 and March 2019, comparing medication errors rates with or without assessments of related harm (actual or potential) before and after EMS implementation. EMS was defined as a computer-based system enabling the prescribing, supply, and/or administration of medicines. Study quality was assessed. Results There was substantial heterogeneity in outcomes of the 18 included studies. Only 2 were strong quality. Meta-analysis of 5 studies reporting change in actual harm post-EMS showed no reduced risk (RR: 1.22, 95% CI: 0.18–8.38, P = .8) and meta-analysis of 3 studies reporting change in administration errors found a significant reduction in error rates (RR: 0.77, 95% CI: 0.72–0.83, P = .004). Of 10 studies of prescribing error rates, 9 reported a reduction but variable denominators precluded meta-analysis. Twelve studies provided specific examples of system-related medication errors; 5 quantified their occurrence. Discussion and Conclusion Despite the wide-scale adoption of EMS in hospitals around the world, the quality of evidence about their effectiveness in medication error and associated harm reduction is variable. Some confidence can be placed in the ability of systems to reduce prescribing error rates. However, much is still unknown about mechanisms which may be most effective in improving medication safety and design features which facilitate new error risks.


2017 ◽  
Vol 20 (4) ◽  
pp. 718-726 ◽  
Author(s):  
Anoukh van Giessen ◽  
Jaime Peters ◽  
Britni Wilcher ◽  
Chris Hyde ◽  
Carl Moons ◽  
...  

2017 ◽  
Vol 26 (23-24) ◽  
pp. 3832-3842 ◽  
Author(s):  
Everistus Ibekwe ◽  
Carol Haigh ◽  
Fiona Duncan ◽  
Francis Fatoye

F1000Research ◽  
2019 ◽  
Vol 8 ◽  
pp. 859 ◽  
Author(s):  
Lucia Giles ◽  
Caroline Freeman ◽  
Polly Field ◽  
Elisabeth Sörstadius ◽  
Bernt Kartman

Background: Heart failure (HF) is increasing in prevalence worldwide. This systematic review was conducted to inform understanding of its humanistic and economic burden. Methods: Electronic databases (Embase, MEDLINE®, and Cochrane Library) were searched in May 2017. Data were extracted from studies reporting health-related quality of life (HRQoL) in 200 patients or more (published 2007–2017), or costs and resource use in 100 patients or more (published 2012–2017). Relevant HRQoL studies were those that used the 12- or 36-item Short-Form Health Surveys, EuroQol Group 5-dimensions measure of health status, Minnesota Living with Heart Failure Questionnaire or Kansas City Cardiomyopathy Questionnaire. Results: In total, 124 studies were identified: 54 for HRQoL and 71 for costs and resource use (Europe: 25/15; North America: 24/50; rest of world/multinational: 5/6). Overall, individuals with HF reported worse HRQoL than the general population and patients with other chronic diseases. Some evidence identified supports a correlation between increasing disease severity and worse HRQoL. Patients with HF incurred higher costs and resource use than the general population and patients with other chronic conditions. Inpatient care and hospitalizations were identified as major cost drivers in HF. Conclusions: Our findings indicate that patients with HF experience worse HRQoL and incur higher costs than individuals without HF or patients with other chronic diseases. Early treatment of HF and careful disease management to slow progression and to limit the requirement for hospital admission are likely to reduce both the humanistic burden and economic impact of HF.


Author(s):  
Andrés Laserna ◽  
Julián Barahona-Correa ◽  
Laura Baquero ◽  
Camilo Castañeda-Cardona ◽  
Diego Rosselli

2014 ◽  
Vol 20 (3) ◽  
pp. 203-207 ◽  
Author(s):  
Thomas C. Hall ◽  
Giuseppe Garcea ◽  
M'Balu A. Webb ◽  
Dhya Al-Leswas ◽  
Matthew S. Metcalfe ◽  
...  

Author(s):  
Arim Kwak ◽  
Yoo Jin Moon ◽  
Yun-Kyoung Song ◽  
Hwi-Yeol Yun ◽  
Kyungim Kim

This systematic review examined the varied studies that have assessed the economic impact of pharmacist-participated medication management for nursing home residents older than 65 years of age. The articles published during 1990–2017 were found through PubMed, EMBASE and Ovid Medline. After the selection process by independent reviewers, a total of 12 studies were included. The quality of the selected articles was assessed using the Effective Public Health Practice Project checklist for economic studies. The articles were highly heterogeneous in terms of study design, pharmacist participation type, and measures of economic outcome. Therefore, the results are presented narratively according to the type of pharmacist involvement featured in the articles: interprofessional networks, interprofessional coordination, or interprofessional teamwork. Of the eight studies performing statistical comparison analyses, one study of interprofessional coordination and three of interprofessional teamwork showed statistically significant positive economic outcomes. The remaining four studies showed non-significant tendencies towards favorable economic outcomes. This review provides insights into the essential features of successful pharmacist-participated medication management for elderly patients in nursing homes.


Sign in / Sign up

Export Citation Format

Share Document